We have previously purified a cytosolic vitamin D metabolite binding protei
n (cDBP) from rat enterocytes, which has characteristics distinct from othe
r vitamin D binding proteins. In these studies, we demonstrate that cDBP in
a semi-purified fraction from human intestinal cells (Caco-2 cells) binds
25-hydroxy-vitamin D (25OHD) with at least a 1000-fold greater affinity tha
n 1,25-dihydroxyvitamin D (1,25(OH)(2)D) or 24,25-dihydroxyvitamin D. Treat
ment of cells with 1,25(OH)(2)D reduced 25OHD binding to approximately one
third that of the untreated cells (0.42 CPM/mg total protein vs 1.34 CPM/mg
total protein, respectively). Finally, the cDBP is not immunoreactive to a
ntibodies prepared against the C-terminus of the nuclear vitamin D receptor
(VDR). In summary, cDBP bound 25OHD with greater affinity than either 1,25
(OH)(2)D or 24,25 dihydroxyvitamin D, the cytosolic binding activity was do
wn-regulated by 1,25(OH)(2)D and cBDP is distinct from the nuclear VDR. (C)
2000 Academic Press.